Oftalmol Zh.2013;4:45-49


Changes in the overall immune status of various types of diabetic macular edema in patients with diabetes mellitus type II

O. Zborowska, N. Preys

SI «The Filatov Institute of Eye Diseases ard Tissue Therapy NAMS

e-mail: rataliya_@bk.ru

The paper presents changes of immune system in different types of DME in patients with diabetes type II. During the work carried out in all patients general ophthalmological examination, PAH and immunological studies. Obtained the following results: for all types DME observed changes of immune status, namely the activation of cellular and humoral immunity and increased sensitization to AG-retinal. Future plans of the required immune.


1.Vanichkin AA, Bushuyeva NN, Degtyarenko TV. Method-ological recommendations. Express initial assessment of immunological status of the individual. Odessa; 1990. 23 p.

2.Vodovozov AM. Fundus examination in the transformed light. M.: Meditsina; 1986. 255 p.

3.Gluzman DF, Sklyarenko LM, Nagornaya VA, Kryachok IA. Diagnostic immunocytochemistry of tumors. Kiev: Mo-rion; 2003. 6- 15.

4.Antcliff RJ, Marshall J. The pathogenesis of edema in dia-betic maculopathy. Semin. Ophthalmol. 1999; 14: 223- 32.
Crossref   Pubmed

5.Ferris FL, Patz A. Macular edema. A complication of diabetic retinopathy. Survey of Ophthalmology. 1984; 28: 14.
Crossref   Pubmed

6.Focus on macular diseases. Sandeeep Saxena, editor. Jaypee Brothers Medical Publishes (P) Ltd.: New Delhi; 2007. 490 p.

7.Michaelson IC. The mode of development of the retina vessels. Trans Ophthalmol Soc UK.1948; 68: 137- 8.

8.Negi A, Vemon SA, Islam MS. Macular oedema. Identifying and quantification. Eye News. 2004; 11(1): 13-8.

9.Nguyen QD, Shah SM, Heier JS et al. Vascular endotheli-um growth factor is a critical stimulus for diabetic macular edema. Am. J. Ophthalmol. 2006; 142: 961- 9.
Crossref   Pubmed